Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

CRUK

- PMLiVE

Envision Pharma Group announces changes in its executive team

Current CEO Brian Hepburn will be succeeded by CCO David Thompson

- PMLiVE

Envision Pharma Group relocates to support expansion

Office moves in the US prompted by significant growth

- PMLiVE

Envision appoints new patient partnerships leader

Joins from Cancer Research UK

- PMLiVE

AZ and CRUK launch Cambridge genomics centre

New centre adds to Cambridge's biotech cluster

- PMLiVE

Envision Pharma Group relocates to support growth

Expands its Horsham to accommodate for additional team members

- PMLiVE

Cancer Research UK to test Asterias’ lung cancer vaccine

The vaccine could treat NSCLC patients who are at risk of relapse

- PMLiVE

Otsuka utilises Envision Pharma Group’s medical affairs platform

The programme offers Otsuka’s stakeholders a more “user friendly” experience

- PMLiVE

NCCN bolsters its Oncology Research Programme

Uses iEnvision to manage the programme’s projects

- PMLiVE

Merck forges closer ties with Cancer Research UK

Will partake in three research projects covering hit discovery to preclinical candidate selection

- PMLiVE

Envision Pharma Group expands with new Cheshire office

Appoints Anne Clare Wadsworth to lead its North West branch

- PMLiVE

Cancer charity partners with research council for innovation

CRUK teams up with multi-disciplinary groups to help develop new oncology products

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links